Phase II trial of SurVaxM combined with standard therapy in patients with newly diagnosed glioblastoma.

被引：1
|
作者：
Ahluwalia, Manmeet Singh
Reardon, David A.
Abad, Ajay P.
Curry, William T.
Wong, Eric T.
Belal, Ahmed
Qiu, Jingxin
Mogensen, Kathleen
Schilero, Cathy
Casucci, Danielle
Mechtler, Laszlo
Uhlmann, Erik J.
Ciesielski, Michael J.
Fenstermaker, Robert
机构：
[1] Cleveland Clin, Cleveland, OH 44106 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[5] Massachusetts Gen Hosp, Boston, MA 02114 USA
[6] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
[7] Roswell Pk Canc Inst, Buffalo, NY USA
[8] Dent Neurol Inst, Buffalo, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.2041
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2041
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial
    Lai, Shuzhen
    Li, Peijing
    Liu, Xiaohui
    Liu, Guihong
    Xie, Tieming
    Zhang, Xing
    Wang, Xiaoxuan
    Huang, Jing
    Tang, Yiqiang
    Liu, Zhigang
    Shen, Guoping
    Li, Chaoming
    Lu, Fangxiao
    Wang, Lei
    Jiang, Fagui
    Sun, Caixing
    Chen, Yuanyuan
    Chen, Ming
    CANCER BIOLOGY & MEDICINE, 2024, 21 (05)
  • [42] Temozolomide in Elderly Patients With Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial
    Perez-Larraya, Jaime Gallego
    Ducray, Francois
    Chinot, Olivier
    Catry-Thomas, Isabelle
    Taillandier, Luc
    Guillamo, Jean-Sebastien
    Campello, Chantal
    Monjour, Annick
    Cartalat-Carel, Stephanie
    Barrie, Maryline
    Huchet, Aymeri
    Beauchesne, Patrick
    Matta, Mona
    Mokhtari, Karima
    Tanguy, Marie-Laure
    Honnorat, Jerome
    Delattre, Jean-Yves
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (22) : 3050 - 3055
  • [43] Addition of bevacizumab to the multi-modality standard of care in patients with newly diagnosed glioblastoma: a phase III trial
    Chinot, O.
    Rouge, T. de La Motte
    Moore, N.
    Zeaiter, A.
    EJC SUPPLEMENTS, 2009, 7 (02): : 497 - 497
  • [44] Chloroquine combined with concurrent radiotherapy and temozolomide for newly diagnosed glioblastoma: a phase IB trial
    Compter, Inge
    Eekers, Danielle B. P.
    Hoeben, Ann
    Rouschop, Kasper M. A.
    Reymen, Bart
    Ackermans, Linda
    Beckervordersantforth, Jan
    Bauer, Noel J. C.
    Anten, Monique M.
    Wesseling, Pieter
    Postma, Alida A.
    De Ruysscher, Dirk
    Lambin, Philippe
    AUTOPHAGY, 2021, 17 (09) : 2604 - 2612
  • [45] Randomized phase II study of axitinib alone or combined with lomustine in patients with recurrent glioblastoma.
    Duerinck, Johnny
    Du Four, Stephanie
    Bouttens, Frank
    Verschaeve, Vincent
    Andre, Chantal
    Van Fraeyenhove, Frank
    Chaskis, Cristo
    D'Haene, Nicky
    Le Mercier, Marie
    Salmon, Isabelle
    Neyns, Bart
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [46] MULTICENTER PHASE II TRIAL OF TALAMPANEL WITH STANDARD RADIATION AND TEMOZOLOMIDE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA: REPORT OF 2-YEAR SURVIVAL DATA
    Grossman, Stuart A.
    Ye, Xiaobu
    Chamberlain, Mark
    Mikkelsen, Tom
    Batchelor, Tracy
    Desideri, Serena
    Fisher, Joy
    Piantadosi, Steven
    Fine, Howard
    NEURO-ONCOLOGY, 2009, 11 (06) : 891 - 892
  • [47] Evaluating the benefit of adaptive randomization in the CC-115 arm of the Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A phase II randomized Bayesian adaptive platform trial in newly diagnosed MGMT unmethylated glioblastoma.
    Rahman, Rifaquat
    Trippa, Lorenzo
    Fell, Geoffrey
    Lee, Eudocia Quant
    Arrillaga-Romany, Isabel
    Touat, Mehdi
    Drappatz, Jan
    Galanis, Evanthia
    Ahluwalia, Manmeet Singh
    Colman, Howard
    Nabors, Louis B.
    Hepel, Jaroslaw T.
    Schiff, David
    Welch, Mary Roberta
    Meredith, David M.
    Chiocca, E. Antonio
    Reardon, David A.
    Ligon, Keith L.
    Alexander, Brian Michael
    Wen, Patrick Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [48] Phase II study of hypofractionated radiation therapy in elderly patients with newly diagnosed glioblastoma with poor prognosis
    Navarria, Pierina
    Pessina, Federico
    Cozzi, Luca
    Tomatis, Stefano
    Reggiori, Giacomo
    Simonelli, Matteo
    Santoro, Armando
    Clerici, Elena
    Franzese, Ciro
    Carta, Giulio
    Nibali, Marco Conti
    Bello, Lorenzo
    Scorsetti, Marta
    TUMORI JOURNAL, 2019, 105 (01): : 47 - 54
  • [49] Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: Phase II clinical trial
    Lanzetta, G
    Campanella, C
    Rozzi, A
    Nappa, M
    Costa, A
    Fedele, F
    Innocenzi, G
    Gagliardi, FM
    Salvati, M
    Minniti, G
    Frati, A
    Frati, L
    Vecchione, A
    ANTICANCER RESEARCH, 2003, 23 (6D) : 5159 - 5164
  • [50] A PHASE 0 'TRIGGER' TRIAL OF NIRAPARIB IN NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS
    Sanai, Nader
    Margaryan, Tigran
    Molloy, Jennifer
    Knight, William
    Harmon, Jocelyn
    Hong, Amy
    Wanebo, John
    Kennedy, William
    Garcia, Michael
    Barani, Igor
    Yoo, Wonsuk
    Tien, An-Chi
    Tovmasyan, Artak
    Mehta, Shwetal
    NEURO-ONCOLOGY, 2022, 24 : 73 - 73
12345